Grace Therapeutics, Inc. (GRCE) — Capital Reinvestment Ratio

Latest as of December 2012: 0.59x

Grace Therapeutics, Inc. (GRCE) has a Capital Reinvestment Ratio of 0.59x as of December 2012, meaning it reinvests 1% of its operating cash flow ($136.29K) in capital expenditures ($80.55K). See GRCE net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.59x
Capex / Operating Cash Flow

Operating Cash Flow

$136.29K
USD

Capital Expenditures

$80.55K
USD

Data as of

Dec 2012
Most recent filing

Annual Capital Reinvestment Ratio for Grace Therapeutics, Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for Grace Therapeutics, Inc. from None to None. For live market cap and broader valuation context, see market value of Grace Therapeutics, Inc..

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow